OptiNose Inc. held a special meeting of stockholders on May 16, 2025. During the meeting, stockholders voted on a proposal to adopt the Agreement and Plan of Merger with Paratek Pharmaceuticals, Inc. and Orca Merger Sub, Inc. This proposal was approved. Additionally, a proposal to approve adjournments of the Special Meeting, if necessary, was deemed unnecessary and was not submitted for approval.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.